These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20979179)

  • 21. Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.
    Hussain M; Vaishampayan U; Du W; Redman B; Smith DC
    J Clin Oncol; 2001 May; 19(9):2527-33. PubMed ID: 11331332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.
    Treat JA; Gonin R; Socinski MA; Edelman MJ; Catalano RB; Marinucci DM; Ansari R; Gillenwater HH; Rowland KM; Comis RL; Obasaju CK; Belani CP;
    Ann Oncol; 2010 Mar; 21(3):540-547. PubMed ID: 19833819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.
    Porta C; Paglino C
    BJU Int; 2011 Mar; 107(5):747-748. PubMed ID: 21355979
    [No Abstract]   [Full Text] [Related]  

  • 24. Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.
    Hansen SW
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):17-9. PubMed ID: 11840416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin.
    Terakawa T; Miyake H; Yokoyama N; Miyazaki A; Tanaka H; Inoue T; Fujisawa M
    Urol Int; 2014; 92(2):180-5. PubMed ID: 24246751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
    Zhu J; Sharma DB; Chen AB; Johnson BE; Weeks JC; Schrag D
    Cancer; 2013 Jun; 119(11):2048-60. PubMed ID: 23564469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy with gemcitabine and paclitaxel in a hemodialysis patient with metastatic urothelial carcinoma].
    Kobayashi Y; Nishimura K; Soda T; Yamanaka K; Hirai T; Kishikawa H; Ichikawa Y
    Hinyokika Kiyo; 2010 Jan; 56(1):29-34. PubMed ID: 20104007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous stem-cell transplant for metastatic renal medullary carcinoma.
    Carden MA; Perdahl-Wallace E; Greenberg J; McCarty JM
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27267. PubMed ID: 29856525
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer.
    Soetekouw PM; Timmer-Bonte JN; van der Drift MA; van Leeuwen F; Wagenaar M; van Die L; Bussink J; Tjan-Heijnen VC
    Int J Clin Oncol; 2013 Dec; 18(6):988-96. PubMed ID: 23011101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
    Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.
    Flaherty KT; Stevenson JP; Hahn SM; Redlinger M; O'Dwyer PJ
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):217-22. PubMed ID: 12811513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
    Gluz O; Nitz U; Liedtke C; Christgen M; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Bangemann N; Lindner C; Kuemmel S; Clemens M; Potenberg J; Staib P; Kohls A; von Schumann R; Kates R; Kates R; Schumacher J; Wuerstlein R; Kreipe HH; Harbeck N
    J Natl Cancer Inst; 2018 Jun; 110(6):628-637. PubMed ID: 29228315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial.
    Xu B; Jiang Z; Kim SB; Yu S; Feng J; Malzyner A; Del Giglio A; Chung HC; Shen LJ; Pen DL
    Breast Cancer; 2011 Jul; 18(3):203-12. PubMed ID: 21465229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.
    Hensley ML; Correa DD; Thaler H; Wilton A; Venkatraman E; Sabbatini P; Chi DS; Dupont J; Spriggs D; Aghajanian C
    Gynecol Oncol; 2006 Aug; 102(2):270-7. PubMed ID: 16490239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
    Paccagnella A; Oniga F; Bearz A; Favaretto A; Clerici M; Barbieri F; Riccardi A; Chella A; Tirelli U; Ceresoli G; Tumolo S; Ridolfi R; Biason R; Nicoletto MO; Belloni P; Veglia F; Ghi MG
    J Clin Oncol; 2006 Feb; 24(4):681-7. PubMed ID: 16446341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.
    Sheng X; Cao D; Yuan J; Zhou F; Wei Q; Xie X; Cui C; Chi Z; Si L; Li S; Mao L; Lian B; Tang B; Yan X; Wang X; Kong Y; Dai J; Bai X; Zhou L; Guo J
    Eur J Cancer; 2018 Sep; 100():1-7. PubMed ID: 29933095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Boyle MG; Bajorin DF
    Cancer; 2007 Feb; 109(3):549-55. PubMed ID: 17200962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.
    Greco FA; Burris HA; Litchy S; Barton JH; Bradof JE; Richards P; Scullin DC; Erland JB; Morrissey LH; Hainsworth JD
    J Clin Oncol; 2002 Mar; 20(6):1651-6. PubMed ID: 11896116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
    Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
    Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].
    Helke C; May M; Hoschke B
    Aktuelle Urol; 2006 Sep; 37(5):363-8. PubMed ID: 17004181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.